CUV 0.14% $14.60 clinuvel pharmaceuticals limited

Shorts - general info, page-115

  1. 578 Posts.
    lightbulb Created with Sketch. 84
    I'm not. Which leads me to believe the stock will continue to trade largely on achievements, not potential. It's something of a shame, but the possibility of excellent future returns is still there albeit slower to be crystallised than it could be. It's also a shame Wolgen's reference library of "successful businesses" appears to be missing the many volumes on corporations which are far from boring and have presented with a comprehensive and inspiring confidence. Your extract does, however, reveal plenty about his attitude.
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.